This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Acorda Therapeutics Inc (ACOR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 182.17M 48.04M 41.88M 57.95M
Receivables 32.21M 30.78M 26.33M 22.83M
Inventories 26.84M 26.17M 20.96M 28.38M
Other Current Assets 7.32M 8.46M 16.48M 6.99M
Total Current Assets 409.14M 367.33M 333.06M 360.94M
Property, Plant & Equipment, Gross 59.82M 25.08M 25.84M 13.49M
Accumulated Depreciation & Depletion 13.73M 8.56M 9.13M 9.63M
Property, Plant & Equipment, Net 46.09M 16.52M 16.71M 3.86M
Intangibles 432.82M 17.46M 9.32M 8.77M
Other Non-Current Assets 9.68M 97.82M 104.61M 5.92M
Total Non-Current Assets 671.54M 239.79M 232.27M 18.55M
Liabilities & Shareholder Equity
Total Assets 1.08B 607.13M 565.33M 379.49M
Accounts Payable 30.99M 15.92M 30.54M 29.99M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 114.38M 96.64M 98.87M 87.34M
Long Term Debt 289.88M 3.23M 4.57M 6.26M
Deferred Income Taxes 23.88M 0.00 0.00 0.00
Other Non-Current Liabilities 112.27M 66.90M 75.97M 80.68M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 426.04M 70.13M 80.54M 86.94M
Total Liabilities 540.42M 166.77M 179.41M 174.28M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 540.26M 440.35M 385.92M 205.21M
Common Par 42.00K 41.00K 40.00K 39.00K
Additional Paid In Capital 761.03M 678.69M 640.67M 614.91M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -220.41M -238.08M -254.52M -409.48M
Treasury Stock -329.00K -329.00K -329.00K -329.00K
Other Equity Adjustments -74.00K 37.00K 62.00K 66.00K
Total Capitalization 830.14M 443.58M 390.49M 211.47M
Total Equity 540.26M 440.35M 385.92M 205.21M
Total Liabilities & Stock Equity 1.08B 607.13M 565.33M 379.49M
Total Common Shares Outstanding 41.87M 40.88M 39.79M 39.33M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 12.42K 12.42K 12.42K 12.42K
Basic Weighted Shares Outstanding 41.15M 40.21M 39.46M 39.00M
Diluted Weighted Shares Outstanding 42.54M 41.68M 40.33M 40.06M
Number of Employees 489 421 378 328
Number of Part-Time Employees 0 0 0 0
ACOR News

ACOR Acorda Therapeutics Inc

Chart of ACOR

Analysts Ratings for ACOR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 4 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ACOR ANALYST REPORT

Brokerage Partners

ACOR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs